Hyperliquid Strategies, Inc. (PURR)
12.18
-0.59
(-4.62%)
USD |
NASDAQ |
Sep 04, 16:00
12.11
-0.07
(-0.57%)
After-Hours: 20:00
Hyperliquid Strategies Enterprise Value : 2.305B for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 2.305B |
| September 03, 2026 | 2.423B |
| September 02, 2026 | 2.132B |
| September 01, 2026 | 2.139B |
| August 31, 2026 | 2.319B |
| August 28, 2026 | 2.190B |
| August 27, 2026 | 2.435B |
| August 26, 2026 | 2.180B |
| August 25, 2026 | 2.243B |
| August 24, 2026 | 1.996B |
| August 21, 2026 | 1.984B |
| August 20, 2026 | 1.884B |
| August 19, 2026 | 1.745B |
| August 18, 2026 | 1.306B |
| August 17, 2026 | 1.296B |
| August 14, 2026 | 1.202B |
| August 13, 2026 | 1.230B |
| August 12, 2026 | 1.216B |
| August 11, 2026 | 1.180B |
| August 10, 2026 | 1.186B |
| August 07, 2026 | 1.228B |
| August 06, 2026 | 1.200B |
| August 05, 2026 | 1.230B |
| August 04, 2026 | 1.228B |
| August 03, 2026 | 1.182B |
| Date | Value |
|---|---|
| July 31, 2026 | 1.108B |
| July 30, 2026 | 1.126B |
| July 29, 2026 | 1.059B |
| July 28, 2026 | 1.097B |
| July 27, 2026 | 1.134B |
| July 24, 2026 | 1.103B |
| July 23, 2026 | 1.168B |
| July 22, 2026 | 1.236B |
| July 21, 2026 | 1.282B |
| July 20, 2026 | 1.276B |
| July 17, 2026 | 1.202B |
| July 16, 2026 | 1.222B |
| July 15, 2026 | 1.388B |
| July 14, 2026 | 1.336B |
| July 13, 2026 | 1.298B |
| July 10, 2026 | 1.376B |
| July 09, 2026 | 1.378B |
| July 08, 2026 | 1.422B |
| July 07, 2026 | 1.503B |
| July 06, 2026 | 1.631B |
| July 02, 2026 | 1.477B |
| July 01, 2026 | 1.509B |
| June 30, 2026 | 1.440B |
| June 29, 2026 | 939.08M |
| June 26, 2026 | 972.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Strive, Inc. (United States) | 2.741B |
| Meridian Holdings, Inc. (California) | 5.765M |
| ACADIA Pharmaceuticals, Inc. | 3.941B |
| Agenus, Inc. | 615.81M |
| Alnylam Pharmaceuticals, Inc. | 35.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 470.89M |
| Revenue (Quarterly) | 6.334M |
| Total Expenses (Quarterly) | -464.56M |
| EPS Diluted (Quarterly) | 2.102 |
| Earnings Yield | 5.33% |
| Normalized Earnings Yield | -15.21 |